2016 Annual Meeting | Management of Migraine and Psychiatric Comorbidities

Date Tuesday 04/19/16

Time 06:30 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Mia T. Minen, MD, FAAN

Topic(s)

Learning Objectives Participants will be familiar with the common psychiatric comorbidities related to migraine, such as anxiety, depression, bipolar disorder, PTSD, and sleep disorders; be able to discuss the various tools available to screen for these disorders during the course of the neurological evaluation; and be able to devise treatment regimens for psychiatric conditions, as well as understand the principles and benefit of non-pharmacologic therapeutic options.

CME Available 2.00 CME credits

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
06:30 AM - 06:35 AM		Introduction to the Field of Neuropsychiatry Mia T. Minen, MD, FAAN
06:35 AM - 06:55 AM		Migraine and Psychiatric Comorbidities: The Epidemiology Mia T. Minen, MD, FAAN
06:55 AM - 07:15 AM		Migraine and Psychiatric Comorbidities: Potential Mechanisms and Treatment Implications Gretchen E. Tietjen, MD
07:15 AM - 07:30 AM		Screening Tools for Psychiatric Comorbidity Elizabeth Seng, PhD
07:30 AM - 07:45 AM		Behavioral Treatment Options for Psychiatric Comorbidity in Migraine Elizabeth Seng, PhD
07:45 AM - 07:55 AM		Pharmacologic Considerations Mia T. Minen, MD, FAAN
07:55 AM - 08:15 AM		Interactive Cases Gretchen E. Tietjen, MD
08:15 AM - 08:30 AM		Question and Answer Mia T. Minen, MD, FAAN, Elizabeth Seng, PhD, Gretchen E. Tietjen, MD

Faculty Disclosures
Elizabeth Seng, PhD	Dr. Seng has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Seng has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Seng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Seng has received research support from NCCIH. Dr. Seng has received research support from Cystic Fibrosis Foundation. The institution of Dr. Seng has received research support from American Heart Association.
Mia T. Minen, MD, FAAN	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Gretchen E. Tietjen, MD	Dr. Tietjen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Tietjen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CME Outfitters. An immediate family member of Dr. Tietjen has stock in Johnson & Johnson.

��ɫ��

��ɫ��